217 related articles for article (PubMed ID: 18583230)
1. [Assessment of the cardiotoxicity of recombinant human endostatin using myocardial biochemical markers in cancer patients].
Qin J; Zhang PH; Qian XY; Kang SJ; Luo RC; Wang YG
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):930-2. PubMed ID: 18583230
[TBL] [Abstract][Full Text] [Related]
2. Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia.
Horacek JM; Pudil R; Tichy M; Jebavy L; Zak P; Slovacek L; Maly J
Exp Oncol; 2007 Sep; 29(3):243-7. PubMed ID: 18004253
[TBL] [Abstract][Full Text] [Related]
3. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.
Horácek JM; Pudil R; Tichý M; Jebavý L; Strasová A; Praus R; Zák P; Malý J
Neoplasma; 2005; 52(5):430-4. PubMed ID: 16151589
[TBL] [Abstract][Full Text] [Related]
4. Assessment of anthracycline-induced cardiotoxicity with biochemical markers.
Horacek JM; Pudil R; Jebavy L; Tichy M; Zak P; Maly J
Exp Oncol; 2007 Dec; 29(4):309-13. PubMed ID: 18199989
[TBL] [Abstract][Full Text] [Related]
5. Cardiac blood biomarkers in patients receiving thoracic (chemo)radiation.
Kozak KR; Hong TS; Sluss PM; Lewandrowski EL; Aleryani SL; Macdonald SM; Choi NC; Yock TI
Lung Cancer; 2008 Dec; 62(3):351-5. PubMed ID: 18462828
[TBL] [Abstract][Full Text] [Related]
6. ProANP and NT-proBNP levels to prospectively assess cardiac function in breast cancer patients treated with cardiotoxic chemotherapy.
Kouloubinis A; Kaklamanis L; Ziras N; Sofroniadou S; Makaritsis K; Adamopoulos S; Revela I; Athanasiou A; Mavroudis D; Georgoulias V
Int J Cardiol; 2007 Nov; 122(3):195-201. PubMed ID: 17289172
[TBL] [Abstract][Full Text] [Related]
7. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
Coppola G; Corrado E; Mulè MC; Augugliaro S; Cucchiara A; Novo G; Amoroso G; Assennato P; Hoffmann E; Vitale F; Novo S
Coron Artery Dis; 2009 May; 20(3):225-9. PubMed ID: 19387249
[TBL] [Abstract][Full Text] [Related]
8. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes.
Cameron SJ; Sokoll LJ; Laterza OF; Shah S; Green GB
Clin Chim Acta; 2007 Feb; 376(1-2):168-73. PubMed ID: 17011538
[TBL] [Abstract][Full Text] [Related]
9. [Plasma levels of N-terminal pro-brain natriuretic peptide and glycogen phosphorylase isoenzyme BB in neonates with asphyxia complicated by myocardial injury].
Lin LX; Mao QH; Zhang ZL; An CX; Kang XG
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Apr; 12(4):252-5. PubMed ID: 20416213
[TBL] [Abstract][Full Text] [Related]
10. Elevation of myeloperoxidase in conjunction with cardiac-specific markers after marathon running.
Melanson SE; Green SM; Wood MJ; Neilan TG; Lewandrowski EL
Am J Clin Pathol; 2006 Dec; 126(6):888-93. PubMed ID: 17074690
[TBL] [Abstract][Full Text] [Related]
11. Serum endostatin levels in patients with lung carcinoma.
Swidzińska E; Ossolińska M; Naumnik W; Trojan S; Chyczewska E
Rocz Akad Med Bialymst; 2005; 50():197-200. PubMed ID: 16358965
[TBL] [Abstract][Full Text] [Related]
12. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D
Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
[TBL] [Abstract][Full Text] [Related]
13. [Study on the clinical value of serum cardiac troponin T in early diagnosing of acute non-Q-wave myocardial infarction and prognostic evaluation].
Zheng Q; Wang WZ; Zhang YX; Wang L; Zhao LJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Mar; 16(3):179-81. PubMed ID: 15009972
[TBL] [Abstract][Full Text] [Related]
14. Comparison of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteria.
Collinson PO; Gaze DC; Morris F; Morris B; Price A; Goodacre S
Ann Clin Biochem; 2006 Jul; 43(Pt 4):273-80. PubMed ID: 16824277
[TBL] [Abstract][Full Text] [Related]
15. Pro-brain natriuretic peptide is a sensitive marker for detecting cardiac metastases in patients with non-small cell lung cancer.
Lafaras C; Mandala E; Saratzis A; Platogiannis D; Barbetakis N; Papoti S; Christopoulou M; Ilonidis G; Bischiniotis T
Onkologie; 2009 Jul; 32(7):389-92. PubMed ID: 19556815
[TBL] [Abstract][Full Text] [Related]
16. Elevated CK-MB mass and plasma brain-type natriuretic peptide concentrations following convulsive seizures in children and adolescents: possible evidence of subtle cardiac dysfunction.
Alehan F; Erol I; Cemil T; Bayraktar N; Ogüs E; Tokel K
Epilepsia; 2009 Apr; 50(4):755-60. PubMed ID: 19183225
[TBL] [Abstract][Full Text] [Related]
17. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines.
Mavinkurve-Groothuis AM; Groot-Loonen J; Bellersen L; Pourier MS; Feuth T; Bökkerink JP; Hoogerbrugge PM; Kapusta L
Pediatr Blood Cancer; 2009 May; 52(5):631-6. PubMed ID: 19127569
[TBL] [Abstract][Full Text] [Related]
18. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
19. [Detection of cardiac troponin and high-sensitivity C reactive protein in children with viral myocarditis].
Guo JG
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1076-7. PubMed ID: 18583269
[TBL] [Abstract][Full Text] [Related]
20. [The clinical significance of the dynamic change in serum cardiac troponin T in burned patients].
Wang T; He W
Zhonghua Shao Shang Za Zhi; 2000 Jun; 16(3):147-9. PubMed ID: 11876859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
